首页> International journal of radiation oncology, biology, physics> Esophageal Toxicity After Dose-Escalated Radiation Therapy for Stage II-III Non-Small Cell Lung Cancer: A Secondary Analysis of the Phase 2 Randomized ARTFORCE PET-Boost Trial.

Esophageal Toxicity After Dose-Escalated Radiation Therapy for Stage II-III Non-Small Cell Lung Cancer: A Secondary Analysis of the Phase 2 Randomized ARTFORCE PET-Boost Trial.

导出 LinkOut

翻译打印收藏纠错

第一作者： Saskia A,Cooke

第一单位： Radiation Oncology, Netherlands Cancer Institute (NKI-AVL), Amsterdam, The Netherlands.

作者： Saskia A,Cooke ^[1] ; José S A,Belderbos ^[1] ; Barbara,Stam ^[1] ; Bart,Reymen ^[2] ; Maarten,Lambrecht ^[3] ; Gitte,Fredberg Persson ^[4] ; Corinne,Faivre-Finn ^[5] ; Edith M T,Dieleman ^[6] ; Judi,van Diessen ^[1] ; Dirk,de Ruysscher ^[2] ; Jan-Jakob,Sonke ^[7]

作者单位： Radiation Oncology, Netherlands Cancer Institute (NKI-AVL), Amsterdam, The Netherlands. ^[1] Radiation Oncology, MAASTRO Clinic, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands. ^[2] Experimental Radiation Oncology, Department of Oncology, KU Leuven - University of Leuven, Leuven, Belgium; Radiotherapy-Oncology, University Hospitals Leuven, Gasthuisberg, Belgium. ^[3] Oncology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark; Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. ^[4] Clinical Oncology, The Christie NHS Foundation Trust, University of Manchester, Manchester, United Kingdom. ^[5] Radiation Oncology, Amsterdam University Medical Centers, location AMC, Amsterdam, The Netherlands. ^[6] Radiation Oncology, Netherlands Cancer Institute (NKI-AVL), Amsterdam, The Netherlands. Electronic address: j.sonke@nki.nl. ^[7]